全文获取类型
收费全文 | 960639篇 |
免费 | 69899篇 |
国内免费 | 1389篇 |
专业分类
耳鼻咽喉 | 13286篇 |
儿科学 | 25503篇 |
妇产科学 | 24231篇 |
基础医学 | 136797篇 |
口腔科学 | 28665篇 |
临床医学 | 84516篇 |
内科学 | 188113篇 |
皮肤病学 | 19679篇 |
神经病学 | 75444篇 |
特种医学 | 37335篇 |
外国民族医学 | 83篇 |
外科学 | 154876篇 |
综合类 | 18385篇 |
现状与发展 | 1篇 |
一般理论 | 279篇 |
预防医学 | 65927篇 |
眼科学 | 21759篇 |
药学 | 74672篇 |
3篇 | |
中国医学 | 2184篇 |
肿瘤学 | 60189篇 |
出版年
2019年 | 6908篇 |
2018年 | 10027篇 |
2017年 | 7813篇 |
2016年 | 8683篇 |
2015年 | 9818篇 |
2014年 | 13243篇 |
2013年 | 19308篇 |
2012年 | 26660篇 |
2011年 | 27840篇 |
2010年 | 16284篇 |
2009年 | 15518篇 |
2008年 | 26876篇 |
2007年 | 27981篇 |
2006年 | 28573篇 |
2005年 | 27386篇 |
2004年 | 26349篇 |
2003年 | 25139篇 |
2002年 | 24707篇 |
2001年 | 54968篇 |
2000年 | 56766篇 |
1999年 | 47180篇 |
1998年 | 11038篇 |
1997年 | 9702篇 |
1996年 | 9762篇 |
1995年 | 9100篇 |
1994年 | 8410篇 |
1993年 | 7680篇 |
1992年 | 35540篇 |
1991年 | 33996篇 |
1990年 | 32801篇 |
1989年 | 31928篇 |
1988年 | 29033篇 |
1987年 | 28297篇 |
1986年 | 26323篇 |
1985年 | 25182篇 |
1984年 | 17854篇 |
1983年 | 15152篇 |
1982年 | 7796篇 |
1979年 | 15779篇 |
1978年 | 10603篇 |
1977年 | 9038篇 |
1976年 | 7876篇 |
1975年 | 8627篇 |
1974年 | 10467篇 |
1973年 | 9862篇 |
1972年 | 9368篇 |
1971年 | 8856篇 |
1970年 | 8423篇 |
1969年 | 7926篇 |
1968年 | 7203篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
2.
3.
Hommes Franziska Mohsenpour Amir Kropff Dana Pilgram Lisa Matusall Svenja von Philipsborn Peter Sell Kerstin 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(1):96-106
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Akteure der öffentlichen Gesundheit (Public Health) tragen wesentlich zu Gesundheitsschutz, -förderung und... 相似文献
4.
5.
Kuo-yi Jade Chang MHealthEc MHM BSc Lisa Lorraine Dillon MSpecEd BPsych Lil Deverell COMS PhD MEd GradDipO&M BEd Mei Ying Boon PhD BOptom FAAO Lisa Keay PhD MPH BOptom 《Clinical & experimental optometry》2020,103(4):434-448
Despite orientation and mobility (O&M) being a significant factor determining quality of life of people with low vision or blindness, there are no gold standard measures or agreement on how to measure O&M performance. In the first part of this systematic review, an inventory of O&M outcome measures used by recent studies to assess the performance of orientation and/or mobility of adults with vision impairment (low vision and blindness) is presented. A wide variety of O&M outcome measures have been implemented in different fields of study, such as epidemiologic research and interventional studies evaluating training, assistive technology, vision rehabilitation and vision restoration. The most frequent aspect of outcome measures is efficiency such as time, distance, speed and percentage of preferred walking speed, followed by obstacle contacts and avoidance, and dis/orientation and veering. Other less commonly used aspects are target identification, safety and social interaction and self-reported outcome measures. Some studies employ sophisticated equipment to capture and analyse O&M performance in a laboratory setting, while others carry out their assessment in real-world indoor or outdoor environments. In the second part of this review, the appropriateness of implementing the identified outcome measures to assess O&M performance in clinical and functional O&M practice is evaluated. Nearly a half of these outcome measures meet all four criteria of face validity (either clinical or functional), responsiveness, reliability and feasibility and have the potential to be implemented in clinical or functional O&M practice. The findings of this review confirm the complicated and dynamic nature of O&M. Multiple measures are required in any evaluation of O&M performance to facilitate holistic assessment of O&M abilities and limitations of each individual. 相似文献
6.
Rupa Narayan MD Traci M. Blonquist MS Ashkan Emadi MD PhD Robert P. Hasserjian MD Meghan Burke BS Christopher Lescinskas BS Donna S. Neuberg ScD Andrew M. Brunner MD Gabriela Hobbs MD Hanno Hock MD PhD Steven L. McAfee MD Yi-Bin Chen MD Eyal Attar MD Timothy A. Graubert MD Christina Bertoli MSN Jenna A. Moran MSN Meghan K. Bergeron MSN Julia E. Foster MSN Aura Y. Ramos BSN Tina T. Som BSN Megan K. Vartanian BSN RN Jennifer L. Story LPN Kristin McGregor MS Molly Macrae BS Tanya Behnan BS Margaret C. Wey PhD Jessica Rae BSN Frederic I. Preffer PhD Patricia Lesho BA Vu H. Duong MD Mason L. Mann BA Karen K. Ballen MD Christine Connolly BS Philip C. Amrein MD Amir T. Fathi MD 《Cancer》2020,126(6):1264-1273
7.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
8.
9.
10.
Stepanova E. S. Makarenkova L. M. Chistyakov V. V. Rybakov Yu. L. Gukasov V. M. Fedotcheva T. A. Parshin V. A. Votyakov V. A. Shimanovskii N. L. 《Pharmaceutical Chemistry Journal》2019,52(12):1016-1020
Pharmaceutical Chemistry Journal - An HPLC-MS method for simultaneous quantitative determination of a novel gestagenic pharmaceutical and two of its metabolites in rat and rabbit blood sera was... 相似文献